首页> 外文OA文献 >PSY12 Factor Consumption for Prophylaxis and Treatment of Bleeding: Recombinant Factor Ix Fc Fusion Protein Compared With Conventional Recombinant Factor Ix

【2h】

PSY12 Factor Consumption for Prophylaxis and Treatment of Bleeding: Recombinant Factor Ix Fc Fusion Protein Compared With Conventional Recombinant Factor Ix

机译：预防和治疗出血的PSY12因子消耗量：重组因子Ix Fc融合蛋白与常规重组因子Ix的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Iorio A; Krishnan S; Myrén K; Lethagen S; McCormick N; Karner P;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates. [J] . Jerry Powell, Amy Shapiro, Margaret Ragni, British Journal of Haematology . 2015,第1期

机译：预防重组因子IX Fc融合蛋白的使用可减少输注，减少因子IX的消耗并降低出血率。
2. Physical activity in individuals with haemophilia and experience with recombinant factor VIII Fc fusion protein and recombinant factor IX Fc fusion protein for the treatment of active patients: a literature review and case reports [J] . Wang Michael, Teresa Alvarez-Roman Maria, Chowdary Pratima, Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis . 2016,第7期

机译：血友病患者的身体活动以及重组因子VIII Fc融合蛋白和重组因子IX Fc融合蛋白在活跃患者中的治疗经验：文献复习和病例报告
3. Alprolix (recombinant Factor IX Fc fusion protein): Extended half-life product for the prophylaxis and treatment of hemophilia B [J] . DucoreJ.M., MiguelinoM.G., PowellJ.S. Expert review of hematology . 2014,第5期

机译：Alprolix（重组因子IX Fc融合蛋白）：延长的半衰期产物，用于预防和治疗B型血友病
4. Glycosylation Profiling of Therapeutically Active Glycoproteins: Identification of Glycans in Recombinant Factor IX using Directed MALDI-QIT-TOF-MS~(n) and a Glycan Database [C] . Matthew E. Openshaw, Daniel I. R. Spencer, Louise Royle, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：治疗活性糖蛋白的糖基化分析：使用指向MALDI-QIT-TOF-MS〜（n）和甘草数据库的重组因子IX中聚糖的鉴定
5. Production of recombinant human coagulation factor IX by transgenic pig [D] . Xu, Weijie 2014

机译：转基因猪生产重组人凝血因子IX
6. Physical activity in individuals with haemophilia and experience with recombinant factor VIII Fc fusion protein and recombinant factor IX Fc fusion protein for the treatment of active patients: a literature review and case reports [O] . Michael Wang, María Teresa Álvarez-Román, Pratima Chowdary, -1

机译：血友病患者的身体活动以及重组因子VIII Fc融合蛋白和重组因子IX Fc融合蛋白在活跃患者中的治疗经验：文献复习和病例报告
7. PSY9 Comparisons of Factor Consumption for Routine Prophylaxis And Bleeding During Episodic Therapy With Recombinant Factor Viii Fc Fusion Protein and Conventional Recombinant Factor Viii [O] . Iorio A, Krishnan S, Myrén K, 2015

机译：重组因子Viii Fc融合蛋白和常规重组因子Viii偶发治疗期间常规预防和出血的因素消耗的PSY9比较

PSY12 Factor Consumption for Prophylaxis and Treatment of Bleeding: Recombinant Factor Ix Fc Fusion Protein Compared With Conventional Recombinant Factor Ix

著录项

引文网络

相似文献

相关主题

期刊订阅